A5045890810- Antifungal resistance and susceptibility
- Innovations in Medical Education
- Antimicrobial Resistance in Staphylococcus
- Pharmaceutical Practices and Patient Outcomes
- Patient Safety and Medication Errors
- Fungal Infections and Studies
- Health and Well-being Studies
- Infections and bacterial resistance
- Education, Achievement, and Giftedness
- Infective Endocarditis Diagnosis and Management
- Innovative Teaching Methods
- Simulation-Based Education in Healthcare
- Grit, Self-Efficacy, and Motivation
- Health and Medical Research Impacts
- Parasitic Infections and Diagnostics
- Antibiotic Resistance in Bacteria
- Opioid Use Disorder Treatment
- Peptidase Inhibition and Analysis
- Cardiac Health and Mental Health
- Bacterial biofilms and quorum sensing
- Patient Satisfaction in Healthcare
- Health and Wellbeing Research
- Diversity and Career in Medicine
- Mycobacterium research and diagnosis
- Diabetes Treatment and Management
Alameda Health System
2019-2020
Sierra View Medical Center
2020
UPMC Health System
2019
Kaiser Permanente San Leandro Medical Center
2018-2019
Touro University California
2014-2017
Kern Medical Center
2016
To determine if Grit-S scores correlate with academic success in a doctor of pharmacy (PharmD) program, as well the pursuit and attainment postgraduate (residency or fellowship) training.
Introduction In the USA over 30% of medication errors occur at point administration. Among non-surgical patients in US hospitals exposed to opioids, 0.6% experience a severe opioid-related adverse event. September 2018, Sierra View Medical Center identified two areas opportunity for quality improvement: bedside bar code administration (BCMA) and pain reassessments. At baseline (April 2018 2018) only 81% medications were scanned prior with reassessments completed 41% time 1 hour postopioid...
Stenotrophomonas maltophilia is an inherently multidrug resistant (MDR) opportunistic pathogen with many mechanisms of resistance. SENTRY studies reveal decreasing sensitivities S. to trimethoprim-sulfamethoxazole and fluoroquinolones. Ceftolozane-tazobactam (Zerbaxa, Merck & Co., Inc.) a novel intravenous combination agent third-generation cephalosporin β -lactamase inhibitor was demonstrated have in vitro activity against Gram-positive, Gram-negative, MDR organisms. Data for...
Abstract Purpose A case report of the use linezolid and daptomycin for treatment multidrug-resistant right-sided infective endocarditis is presented. Summary 36-year-old patient with a history intravenous drug was hospitalized native tricuspid valve resulting in persistent methicillin-resistant Staphylococcus aureus bacteremia. During admission unsuccessfully treated vancomycin monotherapy (final E-test minimum inhibitory concentration, 4 μg/mL). The patient’s switched to gentamicin, no...
Abstract Purpose To describe the development of and implementation a patient-centric clinical indications library (CIL) into prescribing process determine operational humanistic outcomes (from prescriber, pharmacist, patient perspectives) including on outpatient prescription labels. Methods A descriptive retrospective data analysis was conducted. Multiple stakeholder groups were engaged to develop integrate CIL package. After integration, prescribers, pharmacists, patients surveyed. focus...